Consumo de antiinflamatorios no esteroideos en un establecimiento farmacéutico privado de la ciudad de Trujillo, Septiembre 2021 – Agosto 2022
No Thumbnail Available
Date
2022
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
El presente informe es un estudio transversal, retrospectivo y descriptivo que tuvo como objetivo determinar el consumo de antiinflamatorios no esteroideos en un establecimiento farmacéutico privado de la cuidad de Trujillo, provincia de Trujillo del departamento de la Libertad, en donde se llevó a cabo la realización de las prácticas pre profesionales. La determinación del estudio estuvo basada en los datos proporcionados por el registro de ventas manual de dicho establecimiento, la cual permitió observar y obtener la información necesaria de los medicamentos en estudio. Los antiinflamatorios no esteroideos sujeto a estudio, fueron el ácido acetilsalicílico 100 mg (Lab. Labot), ibuprofeno 400 mg (Lab. Genfar), naproxeno sódico 550 mg (Lab. Portugal), diclofenaco 50 mg (Lab. Genfar) y celecoxib 200 mg (Lab. Portugal), bajo la forma farmacéutica de tabletas y cápsula. El consumo de AINE dentro del periodo de estudio, septiembre 2021 – agosto 2022, fue de 731, 1971, 3375, 1073 y 769 unidades dispensadas de ácido acetilsalicílico, ibuprofeno, naproxeno sódico, diclofenaco y celecoxib, respectivamente. El costo anual originado por los medicamentos en estudio fue de S/.146.20; S/.394.20; S/.1350.00; S/.214.60 y S/.384.50 para ácido acetilsalicílico, ibuprofeno, naproxeno sódico, diclofenaco y celecoxib, respectivamente. El consumo expresado en DDD/1000 habitantes/día, fue 0.07; 1.86; 10.49; 1.52 y 2.17, para ácido acetilsalicílico, ibuprofeno, naproxeno sódico, diclofenaco y celecoxib, respectivamente. Concluyéndose, que naproxeno sódico 550 mg es el de mayor dispensación, el de mayor consumo y el de mayor gasto económico.
ABSTRACT This report is a cross-sectional, retrospective and descriptive study that aimed to determine the consumption of non-steroidal anti-inflammatory drugs in a private pharmaceutical establishment in the city of Trujillo, province of Trujillo in the department of La Libertad, where the study was carried out. of pre-professional practices. The determination of the study was based on the data provided by the manual sales record of said establishment, which allowed observing and obtaining the necessary information of the drugs under study. The non-steroidal anti-inflammatory drugs under study were acetylsalicylic acid 100 mg (Lab. Labot), ibuprofen 400 mg (Lab. Genfar), naproxen sodium 550 mg (Lab. Portugal), diclofenac 50 mg (Lab. Genfar) and celecoxib 200 mg (Lab. Portugal), in the pharmaceutical form of tablets and capsules. The consumption of NSAIDs within the study period, September 2021 – August 2022, was 731, 1971, 3375, 1073 and 769 dispensed units of acetylsalicylic acid, ibuprofen, naproxen sodium, diclofenac and celecoxib, respectively. The annual cost originated by the drugs under study was S/.146.20; S/.394.20; S/.1350.00; S/.214.60 and S/.384.50 for acetylsalicylic acid, ibuprofen, sodium naproxen, diclofenac and celecoxib, respectively. The consumption expressed in DDD/1000 inhabitants/day, was 0.07; 1.86; 10.49; 1.52 and 2.17, for aspirin, ibuprofen, naproxen sodium, diclofenac, and celecoxib, respectively. Concluding, that naproxen sodium 550 mg is the one with the highest dispensing, the one with the highest consumption and the one with the highest economic cost.
ABSTRACT This report is a cross-sectional, retrospective and descriptive study that aimed to determine the consumption of non-steroidal anti-inflammatory drugs in a private pharmaceutical establishment in the city of Trujillo, province of Trujillo in the department of La Libertad, where the study was carried out. of pre-professional practices. The determination of the study was based on the data provided by the manual sales record of said establishment, which allowed observing and obtaining the necessary information of the drugs under study. The non-steroidal anti-inflammatory drugs under study were acetylsalicylic acid 100 mg (Lab. Labot), ibuprofen 400 mg (Lab. Genfar), naproxen sodium 550 mg (Lab. Portugal), diclofenac 50 mg (Lab. Genfar) and celecoxib 200 mg (Lab. Portugal), in the pharmaceutical form of tablets and capsules. The consumption of NSAIDs within the study period, September 2021 – August 2022, was 731, 1971, 3375, 1073 and 769 dispensed units of acetylsalicylic acid, ibuprofen, naproxen sodium, diclofenac and celecoxib, respectively. The annual cost originated by the drugs under study was S/.146.20; S/.394.20; S/.1350.00; S/.214.60 and S/.384.50 for acetylsalicylic acid, ibuprofen, sodium naproxen, diclofenac and celecoxib, respectively. The consumption expressed in DDD/1000 inhabitants/day, was 0.07; 1.86; 10.49; 1.52 and 2.17, for aspirin, ibuprofen, naproxen sodium, diclofenac, and celecoxib, respectively. Concluding, that naproxen sodium 550 mg is the one with the highest dispensing, the one with the highest consumption and the one with the highest economic cost.
Description
Keywords
Antiinflamatorio no esteroideos (AINE), Consumo, Costo y dosis diaria definida (DDD).